The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...
And the Chinese IVD market, estimated at 60 billion RMB (approximately ... Researchers typically evaluate circulating tumour DNA (ctDNA) or circulating tumour cells (CTCs) to identify cancer ...
SAN DIEGO--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow ... access to advanced DNA and multi-omic ...
Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback